Koller, William C., 1945-2005
Koller, William C., 1945-
William C. Koller neurologist
Koller, William C.
VIAF ID: 102106980 (Personal)
Permalink: http://viaf.org/viaf/102106980
Preferred Forms
- 200 _ | ‡a Koller ‡b William C. ‡f 1945-....
- 100 1 _ ‡a Koller, William C ‡d 1945-
- 100 1 _ ‡a Koller, William C, ‡d 1945-
- 100 1 _ ‡a Koller, William C.
-
-
-
-
-
-
-
- 100 1 _ ‡a Koller, William C., ‡d 1945-2005
-
- 100 1 _ ‡a Koller, William C., ‡d 1945-2005
-
-
-
- 100 1 _ ‡a Koller, William C., ‡d 1945-2005
- 100 0 _ ‡a William C. Koller ‡c neurologist
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Algorithm (decision tree) for the management of parkinson's disease (2001) : treatment guidelines | |
Algorytm postępowania w chorobie Parkinsona | |
Botulinum toxin in the future : proceedings of the 3rd European Botulinum Toxin Symposium 28 February-2 March 1997, London, UK | |
Complete genomic screen in Parkinson disease: evidence for multiple genes. | |
Cortical disinhibitory signs. | |
Differential diagnosis and treatment of movement disorders | |
Double-blind controlled trial of gabapentin in essential tremor. | |
Early detection of probable idiopathic Parkinson's disease: II. A prospective application of a diagnostic test battery | |
Effect of motor improvement on quality of life following subthalamic stimulation is mediated by changes in depressive symptomatology. | |
Essential tremor in twins: an assessment of genetic vs environmental determinants of etiology | |
Gene-toxin interaction as a putative risk factor for Parkinson's disease with dementia | |
Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease | |
Handbook of clinical neurology. | |
High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease. | |
Identical twins with similar onset of Parkinson's disease: a case report | |
Immediate-release and controlled-release carbidopa/levodopa in PD: a 5-year randomized multicenter study. Carbidopa/Levodopa Study Group | |
The influence of depression on cognition in Parkinson's disease: a pattern of impairment distinguishable from Alzheimer's disease. | |
Lexical, semantic, and action verbal fluency in Parkinson's disease with and without dementia | |
Long-acting levodopa preparations in the management of Parkinson's disease : papers presented at various symposia during the 11th international symposium on Parkinson's disease, Rome, March 16-30, 1994 | |
Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor. | |
Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease | |
Movement disorders : neurologic principles and practice | |
Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. | |
Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism | |
Neurol. dis. ther. | |
Neuropsychological and quality of life outcomes 12 months after unilateral thalamic stimulation for essential tremor | |
Nocardia species as an etiologic agent in Parkinson's disease: serological testing in a case-control study | |
Pallidotomy lesion locations: significance of microelectrode refinement. | |
Parkinsonian syndromes | |
Parkinson's disease and related disorders | |
Pemoline-induced chorea | |
Pharmacokinetic comparison of Sinemet and Atamet (generic carbidopa/levodopa): a single-dose study. | |
The pharmacological evaluation of pergolide mesylate as a potential anti-parkinson agent | |
Preclinical detection of Parkinson's disease. The next frontier: presymptomatic detection. Introduction | |
Primitive reflexes and cognitive function in the elderly. | |
Quality of life in Parkinson's disease | |
The relationship of essential tremor to other movement disorders: report on 678 patients. Essential Tremor Study Group | |
Senile gait: correlation with computed tomographic scans | |
Strategies for treating complications of levodopa therapy | |
Subcutaneous apomorphine in patients with advanced Parkinson's disease: a dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose | |
Sydenham chorea: an update | |
Thalamic stimulation for midbrain tremor after partial hemangioma resection. | |
Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease | |
Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled study | |
Treating motor fluctuations with controlled-release levodopa preparations. | |
Treatment interventions for Parkinson's disease: an evidence based assessment | |
Tremor | |
Unilateral pallidal stimulation for Parkinson's disease: neurobehavioral functioning before and 3 months after electrode implantation | |
United Parkinson Foundation Neurotransplantation Registry: multicenter US and Canadian data base, presurgical and 12 month follow-up |